Why You Might Feel Worse Before Feeling Better On TRT

Testosterone replacement therapy (TRT) is prescribed to address a diagnosed hormonal deficiency, but the first several weeks don't always feel like progress. Many men report temporary increases in fatigue, mood instability, water retention, or acne before symptoms begin to improve. A 2011 review in the European Journal of Endocrinology found that different effects of testosterone treatment appear on distinct timelines, with some benefits taking weeks and others taking months to reach their full effect (Saad et al., 2011). Feeling worse before feeling better on TRT is a recognized part of the adjustment process, not a sign that the treatment has failed.

Understanding why this happens, and when to expect improvement, helps separate a normal adjustment from a protocol that needs attention. Marek Health provides telehealth-based evaluations and ongoing lab monitoring for men with diagnosed testosterone deficiency. Providers use that data to adjust treatment during this transition period.

What Does "Worse Before Better" Mean on TRT?

The phrase describes a temporary period, commonly reported by providers in the first several weeks to months of treatment, when new or worsened symptoms appear despite rising testosterone levels. Providers and clients sometimes call it the adjustment phase or hormonal stabilization period.

"Feeling worse before better" on TRT is a pattern, not a single symptom. It can include any combination of fatigue, anxiety, irritability, disrupted sleep, fluid retention, breast tenderness, or increased acne. These symptoms arise because the body is recalibrating multiple hormonal pathways at once: testosterone itself, estradiol (through aromatization), sex hormone-binding globulin (SHBG), and the hypothalamic-pituitary-gonadal (HPG) axis.

The Endocrine Society guideline recommends monitoring symptoms and labs after initiating therapy, with adjustments based on clinical response (Bhasin et al., 2018). Temporary discomfort during the stabilization window doesn't mean the protocol is wrong, but persistent or severe symptoms do warrant reassessment.

Protocol Design and Early Side Effects

A poorly matched dosing protocol is one of the most common reasons men experience a rough start on TRT. The 2018 AUA guideline emphasizes individualized treatment plans, with dose and delivery method based on lab results, symptom response, and client-specific factors (Mulhall et al., 2018).

Large, infrequent injections (such as 200 mg every two weeks) create pronounced peaks and troughs in serum testosterone. The peak, which providers generally observe within the first day or two after injection, can drive a spike in estradiol through aromatization. The trough, arriving days later, may drop testosterone below the therapeutic range before the next dose. This seesaw pattern produces mood swings, energy fluctuations, and estrogen-related symptoms like nipple sensitivity or water retention.

Smaller, more frequent dosing (two or three times per week for injectable esters) may produce more stable serum levels and is associated with fewer reported side effects in some clients. Men who experience early problems on TRT should discuss injection frequency and delivery method with their provider before assuming the treatment itself is the issue.

How Does Estradiol Affect Early TRT Symptoms?

Testosterone converts to estradiol through the aromatase enzyme, and this process is normal. Estradiol plays a role in bone health and may contribute to cardiovascular, sexual, and cognitive function in men. Problems emerge when estradiol rises too quickly or climbs disproportionately high relative to testosterone.

Men with higher body fat carry more aromatase activity, which means a given testosterone dose may produce more estradiol conversion in one client than another. Symptoms of elevated estradiol include fluid retention, mood changes, breast tissue tenderness, and reduced libido, all of which overlap with common early-TRT complaints.

Many providers monitor estradiol with a sensitive assay as part of TRT follow-up, though not all guidelines require it. A provider can adjust dose, frequency, or body composition strategies based on lab results rather than guessing from symptoms alone.

Routine use of aromatase inhibitors (AIs) to suppress estradiol is not part of standard guideline-based TRT management. The 2018 Endocrine Society guideline's monitoring recommendations for men on TRT do not include AI therapy or routine estradiol targets (Bhasin et al., 2018). When estradiol-related symptoms persist despite dose and frequency adjustments, lab-confirmed elevation may warrant short-term AI use under provider supervision.

Does Injection Frequency Change How TRT Feels?

Pharmacokinetics differ by formulation. Testosterone cypionate and enanthate, the most commonly prescribed injectable esters, have terminal half-lives in the range of one week. A single weekly injection produces a moderate peak-to-trough ratio. Biweekly injections widen that ratio. Splitting the same weekly dose into two or three smaller injections narrows it.

Transdermal gels and creams produce more stable daily levels but may not achieve adequate absorption in all clients. Subcutaneous injections, while not FDA-approved for all testosterone products, are used by some providers and may produce steadier absorption curves than intramuscular delivery in certain clients.

The point: how testosterone is delivered matters as much as how much is prescribed. Men who feel worse during the first weeks of TRT (and those on biweekly injection schedules are the most common example) should ask their provider about total and free testosterone levels measured at both peak and trough before adjusting the dose itself.

Lifestyle Factors That Affect the Adjustment Period

TRT is prescribed to address a hormonal deficiency. It doesn't override the effects of poor sleep, excess body fat, chronic alcohol use, or physical inactivity. These factors each interfere with how the body responds to exogenous testosterone.

Body composition matters. Higher visceral fat is associated with greater aromatase activity, which may increase conversion of testosterone to estradiol and amplify estrogen-related side effects. Poor sleep is associated with reduced endogenous hormone production and may blunt the symptomatic improvement expected from TRT. One frequently overlooked connection is sleep apnea and hormone health; undiagnosed obstructive sleep apnea can persist or worsen on TRT and is itself a cause of fatigue and cognitive symptoms.

Alcohol interferes with hepatic hormone metabolism. Regular intake during the adjustment phase can destabilize the testosterone-to-estradiol ratio and slow the transition toward steady state.

Resistance training and strategies to support natural production (sleep, nutrition, body composition management) work with TRT, not as replacements for it but as factors that determine how well the body uses what it receives.

Could Something Other Than Testosterone Be Causing Symptoms?

The symptoms of testosterone deficiency overlap with many other conditions. Fatigue, mood changes, reduced libido, and cognitive complaints also appear in hypothyroidism, iron deficiency anemia, obstructive sleep apnea, chronic stress with elevated cortisol, and micronutrient deficiencies (vitamin D, zinc, magnesium).

The AUA guideline stresses the importance of a full diagnostic evaluation before starting TRT, including labs to rule out these mimics (Mulhall et al., 2018). Men who begin TRT without addressing these contributing conditions may feel worse because the root problem was never testosterone deficiency alone.

Signs of low testosterone require lab confirmation of consistently low levels, as defined by clinical guidelines and confirmed by a provider, combined with consistent symptoms. If symptoms persist despite adequate testosterone levels, a conversation with the provider about other possible causes is appropriate.

Timeline for Improvement on TRT

A literature review by Saad et al. (2011) mapped the time course of testosterone's effects across published clinical studies. The review found that different outcomes follow different timelines (Saad et al., 2011):

These timelines are population-level averages from published studies. Individual response depends on dose, formulation, baseline health, and other factors. Discuss expected timelines with a provider.

This table explains why the "worse before better" window exists. Benefits arrive in stages, and the early weeks often include side effects (fluid shifts, mood instability, acne) before the body reaches a new steady state. Hematocrit, which rises with erythropoiesis, requires ongoing monitoring because clinically significant increases may not appear until months into therapy.

The FDA's 2025 class-wide labeling update for testosterone products also added a blood pressure warning based on ambulatory monitoring data, while removing the prior cardiovascular boxed warning after the TRAVERSE trial found no increase in major adverse cardiac events (FDA, 2025). The TRAVERSE trial did report higher rates of atrial fibrillation and pulmonary embolism in the testosterone group (Lincoff et al., 2023).

Steps to Take If Symptoms Don't Improve

If symptoms persist beyond the expected adjustment window (roughly 8-12 weeks), a structured reassessment is appropriate. This includes provider-directed lab work to reassess hormone levels and monitor for known risks of therapy, a review of dosing frequency and delivery method, and an honest evaluation of lifestyle factors.

Stopping TRT without a provider-directed plan carries a risk of hormonal disruption, as the HPG axis, suppressed by exogenous testosterone, may take weeks or months to partially recover. The timeline for recovery of sperm production and natural hormone output is variable and not guaranteed (Bhasin et al., 2018). Discontinuation, if needed, should follow a structured taper guided by lab work. More on that process is available at Marek Health's guide to stopping TRT safely.

Adding more medications to counteract side effects (stacking an AI, adding an anxiolytic, adding a sleep aid) is usually not the right first move. Protocol and lifestyle adjustments are the first steps providers consider when addressing early side effects. Individual results vary.

The decision to start, adjust, or stop TRT belongs to the client and provider working together, using lab data and symptom tracking to guide each change. Feeling worse before better on TRT is reported by many clients, and in most cases the pattern is temporary and manageable with provider support. Persistent symptoms warrant reassessment rather than assumptions about the timeline. Fertility considerations add another layer; TRT typically suppresses sperm production to varying degrees, and recovery after cessation is variable, not guaranteed.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

Why might TRT make fatigue or anxiety worse in the first few weeks?

Initial hormone fluctuations, including testosterone peaks and increased estradiol from aromatization, can temporarily worsen fatigue, anxiety, or mood instability. A review of clinical data found that mood-related benefits of testosterone treatment may take 3-6 weeks to appear, with maximum improvement at 18-30 weeks. Adjusting dose frequency and monitoring estradiol can help shorten this window. Individual results vary.

How long does TRT take to start working?

Different effects appear on different timelines. Sexual interest may improve within 3 weeks, while body composition changes can take 12-16 weeks or longer. Full stabilization of mood, energy, and metabolic markers often takes 3-6 months. These timelines assume a properly dosed and monitored protocol.

Does TRT always raise estrogen in men?

Testosterone converts to estradiol through the aromatase enzyme, and some increase is expected and physiologically normal. Problems arise when estradiol rises disproportionately, often due to excess body fat or large infrequent doses. The 2018 Endocrine Society guideline's TRT monitoring recommendations do not include AI therapy or routine estradiol targets. Dose and frequency adjustments are the preferred first step.

Can stopping TRT suddenly cause problems?

Abrupt discontinuation may suppress the hypothalamic-pituitary-gonadal axis, potentially leading to a period of very low testosterone, mood disruption, and fatigue. Recovery of natural production is variable and depends on the duration of use, dose, age, and baseline function. Stopping TRT should always follow a provider-directed plan.

Is it normal to feel worse on a biweekly injection schedule?

Biweekly injections of testosterone cypionate or enanthate create wide swings between peak and trough levels. The AUA guideline recommends individualized protocols to minimize these fluctuations. Splitting the dose into smaller, more frequent injections often reduces mood swings, energy crashes, and estrogen-related symptoms.

Should a provider add more medications if TRT side effects persist?

Stacking additional medications (aromatase inhibitors, sleep aids, anxiolytics) on top of testosterone is often a sign that the protocol itself needs adjustment. Fixing the dose, frequency, or delivery method should be the first step. When lab-confirmed estradiol elevation causes symptoms, a short course of an AI may be appropriate, but long-term suppression of estradiol carries its own risks.

References

• Eur J Endocrinol. 2011;165(5):675-685

• FDA. Class-wide labeling changes for testosterone products. February 28, 2025

• J Clin Endocrinol Metab. 2018;103(5):1715-1744

• J Urol. 2018;200(2):423-432

• N Engl J Med. 2023;389:107-117